|
|
|
Insider
Information: |
Dolsten Mikael |
Relationship: |
Director |
City: |
Madison |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
327,440 |
|
Indirect Shares
|
1,981 |
|
|
Direct
Value |
$9,581,886 |
|
|
Indirect Value
|
$54,319 |
|
|
Total
Shares |
329,421 |
|
|
Total
Value |
$9,636,205 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-16.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Pfizer Inc |
PFE |
President R&D |
2024-02-28 |
321,729 |
2024-02-28 |
1,981 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
5,711 |
2021-09-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PFE |
Pfizer Inc |
President R&D |
|
2019-02-23 |
4 |
D |
$42.96 |
$2,344,241 |
D/D |
(54,568) |
310,078 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2019-02-27 |
4 |
D |
$42.93 |
$3,167,075 |
D/D |
(73,773) |
332,488 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2020-02-26 |
4 |
D |
$34.72 |
$1,312,138 |
D/D |
(37,792) |
307,961 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2020-02-28 |
4 |
D |
$33.42 |
$1,318,285 |
D/D |
(39,446) |
268,515 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2021-02-25 |
4 |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
156,568 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2021-02-25 |
4/A |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
161,568 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2021-02-27 |
4 |
D |
$33.49 |
$798,435 |
D/D |
(23,841) |
137,727 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2022-02-23 |
4 |
D |
$46.87 |
$1,395,179 |
D/D |
(29,767) |
323,862 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2022-02-26 |
4 |
D |
$47.72 |
$1,419,384 |
D/D |
(29,744) |
294,118 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2023-02-22 |
4 |
D |
$42.38 |
$1,381,249 |
D/D |
(32,592) |
391,223 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2023-02-25 |
4 |
D |
$41.75 |
$1,548,007 |
D/D |
(37,078) |
354,145 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2024-02-23 |
4 |
D |
$27.76 |
$689,059 |
D/D |
(24,822) |
343,166 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2024-02-28 |
4 |
D |
$27.04 |
$579,656 |
D/D |
(21,437) |
321,729 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2015-02-25 |
4 |
OE |
$17.69 |
$2,589,745 |
D/D |
146,396 |
502,307 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2016-02-24 |
4 |
OE |
$18.90 |
$3,974,292 |
D/D |
210,280 |
577,902 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2017-02-23 |
4 |
OE |
$21.03 |
$4,593,940 |
D/D |
218,447 |
299,915 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2018-02-24 |
4 |
OE |
$18.90 |
$3,290,131 |
D/D |
174,081 |
225,265 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2018-02-28 |
4 |
OE |
$27.37 |
$5,425,774 |
D/D |
198,238 |
293,352 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2018-09-13 |
4 |
OE |
$21.03 |
$4,462,167 |
D/D |
181,712 |
234,299 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2019-01-31 |
4 |
OE |
$27.37 |
$3,751,425 |
D/D |
125,968 |
362,051 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2019-03-01 |
4 |
OE |
$30.59 |
$3,328,057 |
D/D |
106,191 |
438,679 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2021-11-11 |
4 |
OE |
$22.89 |
$5,014,926 |
D/D |
199,548 |
339,506 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2021-12-17 |
4 |
OE |
$30.17 |
$2,147,712 |
D/D |
71,187 |
351,637 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2022-03-03 |
4 |
OE |
$27.34 |
$3,261,036 |
D/D |
102,460 |
396,578 |
0 |
- |
|
PFE |
Pfizer Inc |
President R&D |
|
2022-11-07 |
4 |
OE |
$30.17 |
$2,627,260 |
D/D |
79,108 |
420,007 |
0 |
- |
|
61 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|